Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Merck spinoff Organon to begin trading in June
Seeking Alpha
Tue, 05/4/21 - 10:47 am
Merck
Organon
spinoff
Women's Health
biosimilars
Pandemic slowed sales of cancer, arthritis, diabetes drugs
Beckers Hospital Review
Mon, 05/3/21 - 10:48 am
COVID-19
pandemic
cancer
diabetes
arthritis
Merck
Keytruda
Amgen
Enbrel
Keytruda should lose stomach cancer indication, says ODAC
Pharmaforum
Fri, 04/30/21 - 11:09 am
Merck
Keytruda
ODAC
gastric cancer
stomach cancer
After $600M sales hit from pandemic, Merck's open to 'all forms' of M&A deals, incoming CEO says
Fierce Pharma
Thu, 04/29/21 - 11:06 pm
Merck
M&A
earnings
Merck, Roche and Bristol Myers nab 4 of 6 positive ODAC votes for ‘dangling’ accelerated approvals
Endpoints
Thu, 04/29/21 - 10:55 pm
Merck
Roche
Bristol Myers Squibb
FDA
ODAC
accelerated approvals
Keytruda
Opdivo
Tecentriq
Merck, GSK vaccine sales hit by pandemic as competitors' business booms
BioPharma Dive
Thu, 04/29/21 - 10:42 pm
Merck
GSK
earnings
Merck Stock Dives As Pandemic Bungles First-Quarter Sales, Earnings
Investors Business Daily
Thu, 04/29/21 - 10:40 pm
Merck
earnings
ODAC votes to keep Keytruda and Tecentriq accelerated approvals in bladder cancer
Endpoints
Wed, 04/28/21 - 10:12 pm
FDA
ODAC
accelerated approvals
Merck
Keytruda
Roche
Tecentriq
Gilead, Merck step in to help India's drug manufacturers fight surging COVID-19 outbreak
Fierce Pharma
Tue, 04/27/21 - 11:26 pm
Gilead Sciences
Merck
India
COVID-19
What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review?
Fierce Pharma
Tue, 04/27/21 - 11:04 am
FDA
oncology
accelerated approvals
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
This Pharma Giant Lost the Vaccine Race, But Its COVID-19 Journey May Not Be Over
Motley Fool
Tue, 04/27/21 - 10:54 am
Merck
COVID-19
FDA Advisory Committee to Review Checkpoint Inhibitors Greenlit Under Accelerated Approval
BioSpace
Sun, 04/25/21 - 01:56 pm
FDA
oncology
cancer
accelerated approvals
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
Merck
Keytruda
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
funding
venture funding
venture capital
AbbVie
Amgen
Boehringer Ingelheim
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Merck KGaA
Pfizer
Roche
Sanofi
Takeda
A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals
BioPharma Dive
Thu, 04/22/21 - 11:52 pm
FDA
cancer immunotherapy
Merck
Roche
Bristol Myers Squibb
AstraZeneca
Biopharma ramps up lobbying spend as drug pricing legislation nears
Endpoints
Wed, 04/21/21 - 10:50 am
drug pricing
lobbying
legislation
GSK
Teva Pharmaceutical
Merck
JNJ
Merck cans one COVID-19 drug, scraps a clinical trial of another
Fierce Biotech
Thu, 04/15/21 - 10:36 am
Merck
COVID-19
MK-7110
OncoImmune
clinical trials
Merck CEO Frazier takes voting-rights fight nationwide, with help from a bigger group of influential execs
Fierce Pharma
Wed, 04/14/21 - 09:46 pm
Merck
Pharma CEOs
Ken Frazier
politics
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
5 takeaways from AACR, one of the year's top meetings on cancer drugs
BioPharma Dive
Mon, 04/12/21 - 11:34 pm
AACR
CAR-T
Merck
Roche
Sanofi
Synthorx
Eli Lilly
Bristol Myers Squibb
Scientists work toward an elusive dream: a simple pill to treat Covid-19
Stat
Fri, 04/9/21 - 10:56 am
COVID-19
drug development
Merck
Ridgeback Biotherapeutics
molnupiravir
Pfizer
Atea Pharmaceuticals
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
…
next ›
last »